Track native and manufactured construct sequences with lossless audits - #428
Merged
Conversation
Contributor
Author
|
Released as Vaxrank 3.15.0 from merge commit 82b1206. Lint passed; full final-commit suite 1,333 passed; all Python 3.10–3.13 PR and post-merge CI jobs passed; B16 CLI smoke produced nonempty PDF/HTML/text/JSON/Excel/CSV reports. deploy.sh completed on clean main, v3.15.0 points to the merge, pip index confirms 3.15.0, and both published PyPI artifact SHA-256 hashes independently match local builds. #421, #426 and #427 are closed. Historical-selection validation (#414), full cleavage maps (#422) and the actual Sid audit (#423) remain separate ongoing work. |
This file contains hidden or bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Sign up for free
to join this conversation on GitHub.
Already have an account?
Sign in to comment
Add this suggestion to a batch that can be applied as a single commit.This suggestion is invalid because no changes were made to the code.Suggestions cannot be applied while the pull request is closed.Suggestions cannot be applied while viewing a subset of changes.Only one suggestion per line can be applied in a batch.Add this suggestion to a batch that can be applied as a single commit.Applying suggestions on deleted lines is not supported.You must change the existing code in this line in order to create a valid suggestion.Outdated suggestions cannot be applied.This suggestion has been applied or marked resolved.Suggestions cannot be applied from pending reviews.Suggestions cannot be applied on multi-line comments.Suggestions cannot be applied while the pull request is queued to merge.Suggestion cannot be applied right now. Please check back later.
Summary
Closes #421.
Closes #426.
Closes #427.
Evidence and boundaries
The independent DYNC1H1 page documents the JLF V2/V3 terminal KK. Solubility rationale is separately attributed to the project owner's report; CSBio involvement remains tentative. No automatic tail design, rank change, clinical safety claim, or claim of historical vaccine selection agreement.
The subsequent #414, #422 and #423 PRs still own historical final-selection comparisons, complete cleavage maps and the real-data combined construct audit. See CONSTRUCT_AUDIT.md for the complete delivery plan.
Completed review and verification